The latest in peptide science
Quarterly roundup of developments across peptide science, drug discovery, and manufacturing.
14 resources · Newest first
Highlights from the 21st Annual Peptide Therapeutics Symposium, covering multi-receptor therapies, AI-driven peptide design, clinical development, delivery, and manufacturing.
Read moreThe third quarter of 2026 brought notable momentum to peptide drug development, marked by an influx of oral peptide drug approvals, novel inhaled peptide delivery models, exciting advances in personalized cancer vaccines, and a welcome shift of attention toward women's health.
Read moreThe second quarter of 2026 has been a bustling period for peptide drug development, with continued growth in obesity and metabolic health and new developments in oncology and pain management. We’ve highlighted advancements spanning Phase 2/3 data in chronic weight management as well as targeted peptide treatments tackling oncology, rare bone disorders, and chronic inflammation.
Read moreThe start of 2026 has shown that the "Peptide Renaissance" is only accelerating. From the landmark approval of the first oral peptide for psoriasis to the massive expansion of the GLP-1 landscape, synthetic peptides continue to move from niche biologics to front-line primary care.
Read moreThere's a lot happening in the peptide world! We share the highlights across the second quarter of 2025 in the peptide space.
Read moreWe are back! In this round up, we share the highlights across the first quarter of 2025 in the peptide space.
Read moreIn this round up, we share the highlights across the second quarter of 2024 in the peptide space.
Read moreIn this round up, we share the top 10 news in the peptide world from March 2024.
Read moreIn this round up, we share the top 10 news in the peptide world from February 2024.
Read moreIn this round up, we share the top 10 news in the peptide world from January 2024.
Read moreCSBio, a leading manufacturer of peptide synthesizers and peptides from Silicon Valley California, is proud to announce the release of the CSBio II Peptide Synthesizer.
Read moreIn this article, we explore the peptide research around the world focused on defeating coronavirus.
Read moreClear your search to browse this collection.
CSBio is a leading peptide instrumentation manufacturing company located in Silicon Valley, California.
CSBio provides research scale peptide synthesizers, pilot scale peptide synthesizers, commercial scale peptide synthesizers, and DNA/RNA oligonucleotide synthesizers.